Leadership Overview
Genetron Holdings has 4 executives leading key functions including strategy, operations, information technology, and human resources.
Driven by innovation, Genetron Holdings is dedicated to advancing precision oncology through molecular profiling and data science, transforming cancer treatment across China and partnering globally.
Driven by innovation, Genetron Holdings is dedicated to advancing precision oncology through molecular profiling and data science, transforming cancer treatment across China and partnering globally.
Leadership Roles at Genetron Holdings
Sizhen Wang - Chief Executive Officer & Co-Founder
Sizhen Wang, the Chief Executive Officer & Co-Founder at Genetron Holdings, directs the company's overarching strategy and vision. Overseeing the integration of molecular biology and data science, Sizhen Wang drives the transformation of cancer treatment through precision oncology. This leadership role involves guiding the development and expansion of Genetron Health's comprehensive oncology portfolio, which spans early screening, diagnosis, treatment recommendations, and continuous disease monitoring. By fostering strategic partnerships with global biopharmaceutical companies, Sizhen Wang ensures the delivery of customized services and products. The Chief Executive Officer & Co-Founder's focus remains on advancing the company's market position in China and solidifying its impact on global cancer care. Sizhen Wang's strategic direction ensures Genetron Health remains at the forefront of innovation in precision oncology.
Victoria Lei - Chief Operating Officer
Victoria Lei, the Chief Operating Officer at Genetron Holdings, executes the operational strategies that underpin the company's precision oncology platform. Overseeing day-to-day business activities, Victoria Lei ensures the seamless integration of molecular profiling and data science across all functional areas. This leadership position involves managing the complex supply chain and operational workflows necessary for Genetron Health's comprehensive oncology portfolio, from early screening to continuous disease monitoring. The Chief Operating Officer drives efficiency and scalability within the organization, supporting the delivery of critical diagnostic and treatment recommendation services. Victoria Lei's operational oversight is crucial for maintaining high standards of service delivery to both domestic and international partners. By optimizing internal processes, Victoria Lei directly contributes to the company's ability to transform cancer treatment and expand its market reach in China and beyond.
David People - Chief Information Officer
David People, the Chief Information Officer at Genetron Holdings, architects and manages the company's advanced technological infrastructure. Overseeing all information systems and data management, David People ensures the secure and efficient handling of sensitive molecular and patient data, critical for precision oncology. This role involves driving the implementation of cutting-edge data science solutions that enhance Genetron Health's cancer molecular profiling capabilities. The Chief Information Officer is responsible for maintaining the integrity and accessibility of the company's digital platforms, supporting both internal research and external client services. David People's leadership ensures that Genetron Health leverages technology to its fullest potential, enabling breakthroughs in cancer treatment and disease monitoring. By safeguarding and optimizing data systems, David People directly supports the company's mission to transform healthcare through innovation.
Todd Liang - Chief Human Resources Officer
Todd Liang, the Chief Human Resources Officer at Genetron Holdings, cultivates the talent and organizational culture essential for a leading precision oncology platform. Overseeing all human capital initiatives, Todd Liang ensures that Genetron Health attracts, develops, and retains top-tier professionals in molecular biology, data science, and clinical research. This leadership role involves developing strategic HR programs that align with the company's mission to transform cancer treatment. The Chief Human Resources Officer manages employee relations, compensation, benefits, and talent acquisition to foster a high-performance environment. Todd Liang's focus on building a robust workforce is critical for supporting the company's comprehensive oncology portfolio and its global partnerships. By championing employee growth and well-being, Todd Liang directly contributes to Genetron Health's sustained innovation and operational excellence in the competitive biotech landscape.
Explore Leadership Teams in Business Services
Brookhaven National Laboratory delivers discovery science and transformative technology to power and secure the nations future. Primarily supported by the U.S. Department of Energys (DOE) Office of Science, Brookhaven Lab is a multidisciplinary laboratory with seven Nobel Prize-winning discoveries, 37 R&D 100 Awards, and more than 70 years of pioneering research.
Company Leadership DS
MC
JL
NCI is attempting to dramatically reduce the prevalence of cancer and improve the lives of cancer patients and their families, through research into prevention and cancer biology, the development of new interventions, and the training and mentoring of new researchers.
Company Leadership SJ
JH
GT
BG
Erba Mannheim specializes in in-vitro diagnostics, offering a wide range of products including instruments and reagents for blood banking, clinical chemistry, critical care, diabetes management, hematology, hemostasis, immunology, urinalysis, and molecular diagnostics. Their advanced diagnostic instruments, such as the H 7100 Advanced Hematology Analyzer and fully automated ELISA processors, cater to the needs of clinical laboratories and research facilities. The company aims to enhance healthcare outcomes through reliable diagnostics and innovative solutions. Their intended clients include healthcare providers, clinical laboratories, and research institutions.
Company Leadership NS
AB
KK
AD
Boditech Med is a global leader in point-of-care testing with a decades-long track record of improving health and quality of life through innovative in-vitro diagnostic solutions. Since its launch in 1998, Boditech has developed 85 biomarkers, which support capillary blood, venous blood, and plasma testing, to meet customers' evolving needs. Listed as a public company on the KOSDAQ, Boditech's products aid patients and clinicians in 120 countries.
Company Leadership EC
EC
YC